Weekly News Brief April 6–10, 2026
To catch up on all of the news from this past week, listen to our weekly news brief for the week of April 6–10, 2026.
This week’s brief covers a “lab-on-a-chip” pharmacotyping platform to predict drug sensitivity in pediatric leukemia, a framework for validating the accuracy and reliability of AI-extracted clinical data, and a deep learning tissue-of-origin model that identified several misdiagnosed cases of lung metastases.
To learn more about the μPharma pharmacotyping platform, read "Microfluidic Machine Learning–Driven Platform Predicts Drug Sensitivity in Pediatric T-ALL," or see the source report in Med.
For more information on the VALID framework, read "Can AI-Extracted EHR Data Be Trusted? The VALID Framework Takes Aim at a Growing Problem," or see the source report in JCO Clinical Cancer Informatics.
To learn more about the GPSai model, read "Tissue-of-Origin AI Model Identifies Cases of Misdiagnosed Lung Metastases," or see the source report in JAMA Network Open.
Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of ASCO AI in Oncology. Contact us with any questions.
The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.